NANOCARRIER-BASED DELIVERY OF 5-FLUOROURACIL IN BREAST CANCER: TARGETING TUMOR MICROENVIRONMENT AND OVERCOMING CHEMORESISTANCE
This review synthesizes recent high-impact literature on nanocarrier-mediated delivery of 5-FU for breast cancer, covering pharmacological considerations, nanocarrier classes, targeted and co-delivery approaches, stimuli-responsive designs, challenges to clinical translation, and emerging trends such as personalized na...